Who are Verisian's investors?

Verisian's investors include Cambridge Angels group, Recode Ventures, Seedcamp, SuperSeed, 6 Dimensions Capital, ManchesterStory Group, LLC.

Verisian

Founded 2023 · 24 employees on LinkedIn · 6 known investors

Find your way into Verisian

Your email: who you already know at Verisian, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Verisian team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.

Biotech Digital Health Healthtech SaaS

Founders & leadership

Board

Sunil GuptaStrategic Advisor

Investors · 6

Cambridge Angels grouplisted by Cambridge Angels groupCambridge · $195K – $1.9M

How we know: Cambridge Angels group's portfolio page · Not right? Tell us

Recode Ventureslisted by Recode VenturesSan Franciscovia Armen A. Vidian · inferred

How we know: Recode Ventures's portfolio page · Not right? Tell us

Seedcamplisted by SeedcampLondon · $378K – $1.1M

How we know: Seedcamp's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

SuperSeedlisted by SuperSeedLondon · $127K – $635K

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

6 Dimensions CapitalreportedGrand Cayman

How we know: a partner's Signal profile · Not right? Tell us

ManchesterStory Group, LLCreportedWest Des Moines

How we know: a partner's Signal profile · Not right? Tell us

Related companies · 3

InstemInstem provides SaaS platforms and services for research and development in the life sciences industry, serving pharmaceutical companies, CROs, CDMOs, academic research institutions, biotechnology firms, industrial organizations, and agrichemical companies.

SaamaSaama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.

NarrativaNarrativa provides generative AI automation for medical writing, focused on drafting patient safety narratives and clinical trial regulatory documentation for pharmaceutical companies. Its platform automates data analysis and narrative authoring to speed up drug trial documentation and regulatory approvals.

Companies working in the same space as Verisian.

Frequently asked questions

What does Verisian do?: Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.
Who are Verisian's investors?: Verisian's investors include Cambridge Angels group, Recode Ventures, Seedcamp, SuperSeed, 6 Dimensions Capital, ManchesterStory Group, LLC.